Latest Balance Sheet News

Page 1 of 609
Microequities’ funds under management fell to approximately $473 million by 31 October as weak small-cap valuations continued to pressure earnings. The funds manager plans to deploy more balance-sheet capital while developing a new fixed income trust.
Claire Turing
Claire Turing
19 Nov 2026
Neometals has completed a A$2 million secured convertible note financing, taking unaudited available cash to approximately A$3.1 million. The funding provides near-term liquidity, but the issued notes add secured obligations and potential future dilution.
Victor Sage
Victor Sage
19 Nov 2026
Resonance Health delivered a $1.5 million profit and positive operating cash flow in every quarter of FY26, while raising $6 million to accelerate three growth programmes. The challenge is replacing a MASH trial that generated 48% of last year’s revenue.
Ada Torres
Ada Torres
19 Nov 2026
AUCyber has emerged from a lower-revenue FY26 with a sharper focus on managed cybersecurity, reporting a $4.7 million improvement in underlying EBITDA and $1.34 million of new university-sector ARR. The company is now targeting MSP acquisitions, a larger SOC operation and sovereign AI services, while a $5.5 million university tender remains uncontracted.
Victor Sage
Victor Sage
19 Nov 2026
Shaver Shop delivered record FY26 sales and gross profit, but rising wages, leases and online costs kept net profit broadly flat. Early FY27 trading remains softer, with like-for-like sales down 2.8% and no full-year guidance provided.
Logan Eniac
Logan Eniac
19 Nov 2026
Associate Global Partners lifted funds under management 20% to $1.672 billion in FY2026, supported by $172 million of net inflows and WCM-related capital raisings. Momentum continued into FY2027, although reported FUM had eased to $1.549 billion by 17 November after renewed market volatility.
Claire Turing
Claire Turing
19 Nov 2026
New Hope has declared a fully franked 15 cent per share FY27 interim dividend while increasing its hybrid securities offer to $500 million. The capital moves give shareholders an earlier cash return as the company prepares for its proposed Malabar combination.
Victor Sage
Victor Sage
19 Nov 2026
Lifestyle Communities has entered FY27 with a substantially stronger balance sheet, after cutting net debt by $186.8 million and unsold inventory by 55% in FY26. The company says demand remains resilient, but slower Victorian property activity is stretching settlement timelines and tempering its next growth phase.
Eva Park
Eva Park
19 Nov 2026
Lark Distilling reported 15.1% FY26 sales growth and entered FY27 debt-free, but shareholders delivered a sharp rebuke on executive pay and director fees. The company now has to turn its new production platform, Signature range and international push into positive operating cash flow.
Victor Sage
Victor Sage
19 Nov 2026
Close the Loop has opened FY27 with $32.4 million in first-quarter revenue, $4.3 million in EBITDA and a substantial reduction in net debt. The company also expects a Citi refinancing to cut annual interest costs by about $1.4 million, although completion remains pending.
Victor Sage
Victor Sage
19 Nov 2026
Actinogen Medical’s pivotal XanaMIA trial produced a mixed result: Xanamem showed a small, non-significant benefit across the full 247-patient population, but a prespecified older-patient analysis found a statistically significant difference in disease stabilisation. The company will continue its open-label extension, suspend future Phase 3 spending and seek development partners.
Victor Sage
Victor Sage
19 Nov 2026
Nufarm has delivered a sharp FY26 recovery in underlying earnings and cash generation, with leverage falling to 2.0 times despite a 7% revenue decline. The statutory loss, no ordinary dividend and ongoing restructuring show the turnaround remains unfinished.
Ada Torres
Ada Torres
19 Nov 2026

Browse the archive

Full archive